Theratechnologies Inc. Common
Market Cap
160M
Short interest (Sep 15)
0.4%
Net Short (Sep 25 ): -1.2%
Borrow Fee
0.69%
Available Shares
0
Price Chart
Company Overview
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.